Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man

Journal of Autonomic Pharmacology
J H HankoC Owman

Abstract

Neuropeptide Y (NPY) has recently been reported to coexist with noradrenaline (NA) in central as well as peripheral noradrenergic nerves. NPY-containing nerve fibres are particularly numerous around blood vessels. Studies were performed on isolated pial arteries as well as on arteries and veins from several peripheral vascular beds from rabbit, cat and man. NPY induced a varying degree of direct contraction of the vessels with an EAm up to 15 mN. Pial arteries were more sensitive than peripheral arteries to NPY (mean EC50 = 7.6 X 10(-9) M). The presence of NPY did not cause any consistent or significant potentiation of the contractile response to NA in any of the vessels tested. Transmural electrical stimulation of the perivascular nerves (including blockade with tetrodotoxin) was performed mainly with auricular artery from the rabbit. Blocking experiments confirmed that the neurogenic contraction was mediated by noradrenergic-type fibres. NPY caused a concentration-related potentiation of the neurally evoked contractile response. The peptide also potentiated the tetrodotoxin-resistant probably non-neurogenic contractions obtained during enhanced electrical field stimulation. It is concluded that NPY interacts with NA during sy...Continue Reading

References

Sep 1, 1967·The Journal of Physiology·B Katz, R Miledi
Dec 8, 1983·Nature·T E AdrianJ M Polak
Nov 21, 1983·Neuroscience Letters·G TerenghiS R Bloom
Oct 1, 1984·British Journal of Pharmacology·L EdvinssonC Wahlestedt
Dec 23, 1983·Neuroscience Letters·L EdvinssonR Uddman
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·K Tatemoto

❮ Previous
Next ❯

Citations

Feb 9, 1988·European Journal of Pharmacology·Y SuzukiT Asano
Feb 6, 1990·European Journal of Pharmacology·V L SavilleG Burnstock
Jun 17, 1992·European Journal of Pharmacology·M T-BenchekrounA Cadieux
Jul 1, 1989·Journal of the Autonomic Nervous System·R MinsonJ Chalmers
Dec 1, 1988·Regulatory Peptides·M Revington, D I McCloskey
Jul 15, 1987·Experientia·J Wharton, S Gulbenkian
Jan 1, 1990·Pharmacology & Therapeutics·M C MioneG Burnstock
May 1, 1991·American Journal of Obstetrics and Gynecology·G Fried, U Samuelson
May 1, 1988·Clinical and Experimental Pharmacology & Physiology·H K Wong-Dusting, M J Rand
Oct 1, 1988·British Journal of Pharmacology·R Andriantsitohaina, J C Stoclet
Sep 1, 1992·Journal of Neurosurgery·R M PlutaE H Oldfield
Jun 1, 1994·Journal of Autonomic Pharmacology·M A TakiyyuddinD T O'Connor
Jul 27, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Kirk W EvansonHeidi A Kluess
Aug 1, 1990·American Journal of Respiratory Cell and Molecular Biology·J N BaraniukM A Kaliner
Jan 1, 1986·Cephalalgia : an International Journal of Headache·C Owman, J E Hardebo
Jan 1, 1988·Pharmacology & Therapeutics·E K Potter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.